These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 592329)

  • 21. Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives.
    Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD
    J Med Chem; 1982 Nov; 25(11):1381-3. PubMed ID: 6815326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between potency and UV spectra of hallucinogenic amphetamines.
    Bailey K; Verner D
    J Pharm Sci; 1972 Mar; 61(3):480-1. PubMed ID: 5013397
    [No Abstract]   [Full Text] [Related]  

  • 23. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents.
    Repke DB; Grotjahn DB; Shulgin AT
    J Med Chem; 1985 Jul; 28(7):892-6. PubMed ID: 4009612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
    Kovar KA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity studies on hallucinogenic phenylalkylamines using Fujita-Ban approach.
    Bindal MC; Singh P; Gupta SP
    Arzneimittelforschung; 1982; 32(7):719-21. PubMed ID: 6889869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational study of lysergic acid derivatives in relation to their hallucinogenic and antiserotonin activities.
    Kumbar M
    NIDA Res Monogr; 1978; (22):374-407. PubMed ID: 101885
    [No Abstract]   [Full Text] [Related]  

  • 28. [Research on the central activity and analgesia of N-substituted analogs of the amphetamine derivative 3,4-methylenedioxyphenylisopropylamine].
    Braun U; Shulgin AT; Braun G
    Arzneimittelforschung; 1980; 30(5):825-30. PubMed ID: 7190428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-hydroxylated N,N-dimethyltryptamines and hallucinogenic potency.
    Uyeno ET
    Proc West Pharmacol Soc; 1969; 12():118-23. PubMed ID: 4980529
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of [3H]5-HT binding to rat brain membranes by psychotomimetic amphetamines.
    De Jong AP; Huggins F; Fournier D; Makriyannis A
    Eur J Pharmacol; 1982 Sep; 83(3-4):305-8. PubMed ID: 7173311
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.
    Nichols DE
    J Psychoactive Drugs; 1986; 18(4):305-13. PubMed ID: 2880944
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
    Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
    Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
    [No Abstract]   [Full Text] [Related]  

  • 33. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters.
    Clare BW
    J Med Chem; 1990 Feb; 33(2):687-702. PubMed ID: 2299636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
    Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
    J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the conformations of hallucinogenic molecules and their correlation.
    Chothia C; Pauling P
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1063-70. PubMed ID: 4311249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 4-substitution on psychotomimetic activity of 2,5-dimethoxy amphetamines as studied by means of different substituent parameter scales.
    Neuvonen K; Neuvonen H; Fülöp F
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3495-8. PubMed ID: 16644223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues.
    Domelsmith LN; Eaton TA; Houk KN; Anderson GM; Glennon RA; Shulgin AT; Castagnoli N; Kollman PA
    J Med Chem; 1981 Dec; 24(12):1414-21. PubMed ID: 7310818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular orbital studies on the conformation of hallucinogenic indolealkylamines and related compounds. The isolated molecules and the solvent effect.
    Pullman B; Courrière P; Berthod H
    J Med Chem; 1974 Apr; 17(4):439-47. PubMed ID: 4524607
    [No Abstract]   [Full Text] [Related]  

  • 40. Benzofuran bioisosteres of hallucinogenic tryptamines.
    Tomaszewski Z; Johnson MP; Huang X; Nichols DE
    J Med Chem; 1992 May; 35(11):2061-4. PubMed ID: 1534585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.